News

Article

I Can’t Believe I’m Here: A Poem About Breast Cancer

Author(s):

I had been diagnosed with triple-negative breast cancer just three months after my mother passed away from the same disease.

A well-worn, padded reclining chair

I can’t believe I’m here

A cozy, extra soft blanket tucked around my toes

I can’t believe I’m here

A squishy, fresh-smelling pillow behind my head

I can’t believe I’m here

A rolling snack wagon with my favorite cookies

I can’t believe I’m here

A gentle hand helping me up

I can’t believe I’m here

A friendly neighbor sharing her story

I can’t believe I’m here

A turkey sandwich and a cool drink

I can’t believe I’m here

My first chemo treatment

I CAN’T BELIEVE I’M HERE!

I wrote this poem after receiving chemo at Danbury hospital in 2005. I had been diagnosed with triple-negative breast cancer just three months after my mother passed away from the same disease. Although the care during chemo was exemplary and I was treated royally it was still chemo. Thankfully I am cancer free now and living my best life.


This post was written and submitted by Joyce Wigler. The article reflects the views of Wigler and not of CURE®. This is also not supposed to be intended as medical advice.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
Image of two doctors with text.
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.